The gel base give an immediate improvement and then breaks down over a period of weeks
Results of fat dissolving in arms are permanent because the destroyed fat cells do not regenerate
Clinical Data from Competitor Agents: Strengths and Limitations of CT-388 in Light of Competitor Data: Strengths: - CT-388 demonstrates a positive safety and tolerability profile with manageable GI-related side effects that are consistent with the incretin class.- CT-388 has shown statistically significant weight loss across cohorts in its Phase 1/2 trial, with the highest dose cohort (Cohort 8) averaging an 8.4% weight loss at four weeks.- The prolonged half-life of CT-388 suggests the potential for once-weekly dosing, which could bolster adherence compared to therapies requiring more frequent administration.- Weight loss with CT-388 is accompanied by improvements in metabolic parameters such as waist circumference and HOMA-IR, indicating a potential benefit for patients with obesity and associated comorbidities
Many active adults train 56 days a week yet still carry excess fat due to hormonal, metabolic, or appetite-related challenges
Importantly, if you have unexpectedly high B12 levels without taking supplements or receiving injections, this warrants GP review as it may indicate underlying liver disease, kidney disease, or certain blood disorders